Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study

Caterina Lapucci; Jessica Frau; Eleonora Cocco; Giancarlo Coghe; Maria Petracca; Roberta Lanzillo; Vincenzo Brescia Morra; Carolina Gabri Nicoletti; Doriana Landi; Girolama Marfia; Marco Vercellino; Paola Cavalla; Assunta Bianco; Massimiliano Mirabella; Valentina Torri Clerici; Eugenia Tomas; Maria Teresa Ferrò; Paola Grossi; Agostino Nozzolillo; Lucia Moiola; Mauro Zaffaroni; Marco Ronzoni; Federica Pinardi; Giovanni Novi; Maria Cellerino; Antonio Uccelli; Matilde Inglese

doi:10.1177/13524585241266509

Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study

Caterina Lapucci, Jessica Frau, Eleonora Cocco, Giancarlo Coghe, Maria Petracca, Roberta Lanzillo, Vincenzo Brescia Morra, Carolina Gabri Nicoletti, Doriana Landi, Girolama Marfia, Marco Vercellino, Paola Cavalla, Assunta Bianco, Massimiliano Mirabella, Valentina Torri Clerici, Eugenia Tomas, Maria Teresa Ferrò, Paola Grossi, Agostino Nozzolillo, Lucia MoiolaMauro Zaffaroni, Marco Ronzoni, Federica Pinardi, Giovanni Novi, Maria Cellerino, Antonio Uccelli, Matilde Inglese

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

Lingua originale	English
pagine (da-a)	N/A-N/A
Rivista	Multiple Sclerosis
Volume	30
DOI	https://doi.org/10.1177/13524585241266509
Stato di pubblicazione	Pubblicato - 2024

Keywords

Multiple sclerosis
alemtuzumab
efficacy
induction
ocrelizumab
safety
therapy

Accesso al documento

10.1177/13524585241266509

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Lapucci, C., Frau, J., Cocco, E., Coghe, G., Petracca, M., Lanzillo, R., Brescia Morra, V., Nicoletti, C. G., Landi, D., Marfia, G., Vercellino, M., Cavalla, P., Bianco, A., Mirabella, M., Torri Clerici, V., Tomas, E., Ferrò, M. T., Grossi, P., Nozzolillo, A., ... Inglese, M. (2024). Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study. Multiple Sclerosis, 30, N/A-N/A. https://doi.org/10.1177/13524585241266509

@article{b5c5b023485943898bac2b00b476c96c,

title = "Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study",

keywords = "Multiple sclerosis, alemtuzumab, efficacy, induction, ocrelizumab, safety, therapy, Multiple sclerosis, alemtuzumab, efficacy, induction, ocrelizumab, safety, therapy",

author = "Caterina Lapucci and Jessica Frau and Eleonora Cocco and Giancarlo Coghe and Maria Petracca and Roberta Lanzillo and {Brescia Morra}, Vincenzo and Nicoletti, {Carolina Gabri} and Doriana Landi and Girolama Marfia and Marco Vercellino and Paola Cavalla and Assunta Bianco and Massimiliano Mirabella and {Torri Clerici}, Valentina and Eugenia Tomas and Ferr{\`o}, {Maria Teresa} and Paola Grossi and Agostino Nozzolillo and Lucia Moiola and Mauro Zaffaroni and Marco Ronzoni and Federica Pinardi and Giovanni Novi and Maria Cellerino and Antonio Uccelli and Matilde Inglese",

year = "2024",

doi = "10.1177/13524585241266509",

language = "English",

volume = "30",

pages = "N/A--N/A",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "Basingstoke: Stocktom, 1995-. United Kingdom: Arnold",

}

Lapucci, C, Frau, J, Cocco, E, Coghe, G, Petracca, M, Lanzillo, R, Brescia Morra, V, Nicoletti, CG, Landi, D, Marfia, G, Vercellino, M, Cavalla, P, Bianco, A, Mirabella, M, Torri Clerici, V, Tomas, E, Ferrò, MT, Grossi, P, Nozzolillo, A, Moiola, L, Zaffaroni, M, Ronzoni, M, Pinardi, F, Novi, G, Cellerino, M, Uccelli, A & Inglese, M 2024, 'Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study', Multiple Sclerosis, vol. 30, pagg. N/A-N/A. https://doi.org/10.1177/13524585241266509

TY - JOUR

T1 - Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study

AU - Lapucci, Caterina

AU - Frau, Jessica

AU - Cocco, Eleonora

AU - Coghe, Giancarlo

AU - Petracca, Maria

AU - Lanzillo, Roberta

AU - Brescia Morra, Vincenzo

AU - Nicoletti, Carolina Gabri

AU - Landi, Doriana

AU - Marfia, Girolama

AU - Vercellino, Marco

AU - Cavalla, Paola

AU - Bianco, Assunta

AU - Mirabella, Massimiliano

AU - Torri Clerici, Valentina

AU - Tomas, Eugenia

AU - Ferrò, Maria Teresa

AU - Grossi, Paola

AU - Nozzolillo, Agostino

AU - Moiola, Lucia

AU - Zaffaroni, Mauro

AU - Ronzoni, Marco

AU - Pinardi, Federica

AU - Novi, Giovanni

AU - Cellerino, Maria

AU - Uccelli, Antonio

AU - Inglese, Matilde

PY - 2024

Y1 - 2024

KW - Multiple sclerosis

KW - alemtuzumab

KW - efficacy

KW - induction

KW - ocrelizumab

KW - safety

KW - therapy

KW - Multiple sclerosis

KW - alemtuzumab

KW - efficacy

KW - induction

KW - ocrelizumab

KW - safety

KW - therapy

UR - http://hdl.handle.net/10807/289896

U2 - 10.1177/13524585241266509

DO - 10.1177/13524585241266509

M3 - Article

SN - 1352-4585

VL - 30

SP - N/A-N/A

JO - Multiple Sclerosis

JF - Multiple Sclerosis

ER -